196399-22-1Relevant academic research and scientific papers
NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF
-
Paragraph 00169, (2020/12/01)
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
Isoxazolines as Therapeutic Agents
-
Paragraph 0909, (2013/03/26)
The present invention provides compound of Formula (I) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions.
DIFLUOROBENZENE DERIVATIVE AND NEMATIC LIQUID CRYSTAL COMPOSITION MAKING USE OF THE SAME
-
Page/Page column 19; 20, (2008/06/13)
A nematic liquid crystal composition of the present invention includes one or at least two compounds represented by general formula (I) as a first component; and one or at least two compounds represented by general formula (II) as a second component, wherein a dielectric anisotropy is negative. The use of this nematic liquid crystal composition can provide a highly reliable liquid crystal display element capable of maintaining a high voltage-holding ratio even in a high temperature region, and achieving quick responsiveness without reducing the cell gap.
